Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Investment Development is a specialized biotechnology and investment firm focused on the development and commercialization of innovative medical technologies and therapeutic agents. The company operates primarily by identifying high-potential early-stage assets and providing the necessary capital and clinical development expertise to advance them through the regulatory pipeline. Their portfolio includes a diverse range of modalities, including small molecules and biologics, with a strong emphasis on oncology and immunology. Investment Development aims to bridge the gap between academic research and market-ready healthcare solutions through strategic partnerships and internal development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investment Development.